U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06976099) titled 'Multicenter Prospective Cohort Study of Hypertriglyceridemia Acute Pancreatitis' on March 10.
Brief Summary: Hypertriglyceridemia-associated acute pancreatitis (HTG-AP) is the second leading cause in China and is receiving increasing global attention. Research on HTG-AP has been hindered by the heterogeneity and complexity of the disease, as well as the limitations of prior single-center studies with small sample sizes, inadequate collection of clinical data, lack of sustainable follow-up, and insufficient tools for large-scale data collection, analysis, and biomarker testing. To address these unique challenges and leverage the oppor...